Navigation Links
OPPI Opposes Draft National Pharmaceuticals Policy

Coming down heavily on the draft National Pharmaceuticals Policy, industry body OPPI has said the proposed policy will hamper the growth of the pharmaceutical sector // and lead to the destruction of Indian pharma companies.

"The previous governments had reduced the number of drugs under control from 347 to 143 and finally to 74. The Drug Policy in February 2002 had proposed a further reduction from 74 to about 30. The current policy hence will not promote the industry but would hamper its growth," Director General of Organisation of Pharmaceutical Producers of India Ajit V Dangi told PTI.

"The move (of bringing more drugs under price control) will act as a barrier to our growing markets and it will lead to the destruction of Indian Pharma companies," he said.

Instead of widening the list of drugs under the price control regime, the government should ensure access to basic healthcare facilities, Dangi added.

Criticising the proposal to include 354 drugs in the price control regime, he said it would drastically hit the margins of drug manufacturers.

He said the prices of medicines were already lowest in India, even lower than other neighbouring countries like Bangladesh, Sri lanka and Indonesia and there were no apparent reasons to reduce them further.

If the government wanted to lower it further then it should be looking at drugs taxation, he observed. The easier way to reduce prices is to cut taxes such as excise duty which push the prices of medicines up by 75 percent.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. HIV Patients Opposes Patenting Of AIDS Drug
2. Goa Christian Council Opposes Mandatory HIV Test
3. Smoking Ban Draft Is Put For Consultation
4. Kerala Drafts a New Health Tourism Policy
5. National Lung Study in the process
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. Hepatitis B Vaccine To Be Included In National Immunization Programme
8. UK Govt Says On Course For National Chlamydia Screening
9. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
10. India extends National TB Control Program
11. President and Founder of National Obesity Forum Resigns
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... ... ... Seamild, the largest manufacturer of oats in China, is now aiming at global ... is recognized globally as one of the healthiest cereals, XieQingkui, the founder of Seamild, ... move to sow the seed of good karma. Buddhism spirit featuring benevolence and sacrifice ...
(Date:1/21/2017)... Pekin, IL (PRWEB) , ... January 21, 2017 , ... ... disorders. Even when individuals experience the freedom of recovery, they often feel shame for ... abuse and post-traumatic stress disorder (PTSD). In the workshop, “Rising Strong in Life After ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and ... essential oils, announced the company had a successful visit to the 2017 ECRM Diet, ... gives companies that work in the nutritional, sports and health industries a chance to ...
(Date:1/20/2017)... ... January 20, 2017 , ... International Protein, a company based out ... announced it attended the January ECRM trade show in Hilton Head, SC. , ... was determined to create a line of products that would elevate her fitness regime. ...
(Date:1/20/2017)... ... ... “The Angel”: a heartwarming and earnest tale of faith and believing in the ... is the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, alumnus of ... asked of her new book, Marjorie says, “‘The Angel’ was written as a fairytale, ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 Conference Call and Webcast to ... ) today announced it will release results for the fourth quarter ... ... host a conference call at 4:30 PM ET on Wednesday, February ... full year 2016 financial results and other corporate activities. To participate ...
(Date:1/19/2017)... , Jan. 19, 2017 This report ... current and future scenario of the global market. Large ... opioid consumption. Severe chronic constipation is a major side ... traditional laxatives. Hence, novel targeted therapy has been prescribed ... sufferers, launch of targeted medicines, and growing awareness about ...
(Date:1/19/2017)...  Stealth BioTherapeutics Inc. ( Stealth ), a clinical-stage ... announced new additions to its senior leadership team: ... and Daniel Geffken as interim Chief Financial ... , Pharm.D. has been promoted to Chief Clinical Development ... Doug and Daniel to our management team, as both ...
Breaking Medicine Technology: